Medication Error Benchmarking
Contents |
is the definition of a medication error? What are the “ten key elements” of the medication-use system? Won’t medication errors be prevented if nurses just follow the “Five Rights?” What are
Rate Of Medication Errors In Hospitals
"high-alert" medications? What abbreviations are dangerous? Are these evidence based? What drug names medication error rate calculation are frequently confused? How should tall man lettering be applied to differentiate look-alike/sound-alike drug names? What is confirmation bias? medication error definition How do I do an independent double check? How can I measure culture? Should a healthcare practitioner be disciplined for being involved in an error? How can I assess risk? What is
Medication Errors In Nursing
the difference between high-leverage and low-leverage safety strategies? What is an FMEA, and how can I use it? How do I join ISMP? What ISMP resources are available for consumers? Why are standard concentrations safer than using the Rule of 6 for pediatric drips? What tools does ISMP have to satisfy regulatory or insurance network inclusion requirements for community pharmacies to demonstrate participation and
Medication Errors Statistics
knowledge in medication safe practices? Is there a way to get involved with ISMP as a student? Does ISMP have a nationally registered student-organization? 1. What is the national medication error rate? What standards are available for benchmarking? A national or other regional medication error rate does not exist. It is not possible to establish a national medication error rate or set a benchmark for medication error rates. Each hospital or organization is different. The rates that are tracked are a measure of the number of reports at a given institution not the actual number of events or the quality of the care given. Most systems for measuring medication errors rely on voluntary reporting of errors and near-miss events. Studies have shown that even in good systems, voluntary reporting only captures the "tip of the iceberg." For this reason, counting reported errors yields limited information about how safe a medication-use process actually is. It is very possible that an institution with a good reporting system, and thus what appears to be a high error "rate," may have a safer system. For more detailed information see Medication Errors, a book availabl
Know Governance Job Openings Login to PA-PSRS About PA-PSRS Data Interface Facility Reporting Information Login to PassKey About PassKey Advisory Library Patient and Consumer Tips Press Releases Healthcare-Associated Infections Brochures Related Organization Links The Authority medication error statistics 2015 in the News Driving Change Patient Safety Tools Calendar Public Meetings ADDRESS: Patient
Types Of Medication Errors
Safety Authority 333 Market Street Lobby Level Harrisburg, PA 17120 Phone: 717-346-0469 Fax: 717-346-1090 SearchAdvanced Search Understanding the benchmark data for medication errors Benchmarking Process PA PSRS Patient Saf Advis 2004 Dec;1(4):19. _______________This article is excerpted from the book Medication Errors by Michael Cohen, RPh, MS, ScD. Dr. Cohen is President of the Institute for http://www.ismp.org/faq.asp Safe Medication Practices (ISMP) and serves as an expert advisor to PA-PSRS in the area of medication safety._______________Benchmarking is an ongoing process that determines how other organizations have achieved optimal performance. Through the process of benchmarking, ways are suggested for adapting the best practices that result in exception performance. Although measurement is one of its components, effective benchmarking is a dual process that requires two http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2004/dec1(4)/Pages/19.aspx products: performance measurement and enablers.Benchmarks are measures of comparative performance that answer the question: What is your level of performance? By itself, this information has little use in improving performance. To be effective, benchmarking must also provide a systematic method of understanding the underlying process that determines an organization’s performance. To that end, enablers must be identified. Enablers are the specific practices that lead to exemplary performance; they answer the question: How do you do it? Overlooking either one of these components in the benchmarking process renders it useless, even dangerous.Although medication error rates, for example, may seem ideal for benchmarking, we must question the wisdom of applying the benchmarking concept to the medication use process when the focus is on error rates. Certainly, the confusion surrounding the term “benchmarking” perpetuates the myth that one can gauge the quality and safety of the medication use process simply by comparing error rates, both within an organization and externally. The true incidence of medication errors varies, however, depending heavily on the rigor with which the events are clearly identified and reported.Because many medication errors cause no harm to patients, they remain undetected or unreported.
Me Forgot Password? Login or Sign up for a Free Account My Topics of Interest My CME My Profile Sign Out Home Topics Issues WebM&M Cases Perspectives Primers Submit Case CME / CEU Training Catalog Info Glossary About PSNet Help & FAQ https://psnet.ahrq.gov/primers/primer/23/medication-errors Contact PSNet Email Updates Editorial Team Technical Expert/Advisory Panel Terms & Conditions / Copyright PSNet Privacy Policy External Link Disclaimer Patient Safety Primer Last Updated: March 2015 Medication Errors Topics Resource Type Patient Safety Primers Safety Target Medication Errors/Preventable Adverse Drug Events Look-Alike, Sound-Alike Drugs More Share Facebook Twitter Linkedin Email Print Background and definitions Prescription medication use is widespread, complex, and increasingly risky. Clinicians have access to an armamentarium medication error of more than 10,000 prescription medications, and nearly one-third of adults in the United States take 5 or more medications. Advances in clinical therapeutics have undoubtedly resulted in major improvements in health for patients with many diseases, but these benefits have also been accompanied by increased risks. An adverse drug event (ADE) is defined as harm experienced by a patient as a result of exposure to a medication, and ADEs account for of medication errors nearly 700,000 emergency department visits and 100,000 hospitalizations each year. ADEs affect nearly 5% of hospitalized patients, making them one of the most common types of inpatient errors; ambulatory patients may experience ADEs at even higher rates. Transitions in care are also a well-documented source of preventable harm related to medications. As with the more general term adverse event, the occurrence of an ADE does not necessarily indicate an error or poor quality care. A medication error refers to an error (of commission or omission) at any step along the pathway that begins when a clinician prescribes a medication and ends when the patient actually receives the medication. Preventable adverse drug events result from a medication error that reaches the patient and causes any degree of harm. It is generally estimated that about half of ADEs are preventable. Medication errors that do not cause any harm—either because they are intercepted before reaching the patient, or by luck—are often called potential ADEs. An ameliorable ADE is one in which the patient experienced harm from a medication that, while not completely preventable, could have been mitigated. Finally, a certain percentage of patients will experience ADEs even when medications are prescribed and administered appropriately; these are considered adverse drug reactions or non-preventable ADEs (and are popularly k